Chris Ogden
Chief Financial Officer
Replay available
CytomX Therapeutics, Inc. (CTMX) Q3 2025 Earnings Call
CytomX Therapeutics, Inc. (NASDAQ: CTMX) Q3 2025 earnings conference call, held 2025-11-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Sean McCarthy
Chief Executive Officer and Chairman
Edward Tenthoff
Analyst, Piper Sandler
Olivia Brea
Analyst, Cantor Fitzgerald
Matthew Biegler
Analyst, Oppenheimer & Co.
Barclays Analyst
Analyst, Barclays
Mitchell Kapoor
Analyst, H.C. Wainwright
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Cytomx Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:02.313 Good afternoon, everyone. Thank you for standing by. 00:00:02.313 -- 00:00:07.439 Welcome to the Cytomics Therapeutics Third Quarter 2025 Financial Results 00:00:07.439 -- 00:00:11.483 Call. Please be advised that today's call is being recorded. 00:00:11.483 -- 00:00:15.908 I would now like to hand the call over to your host for today, Chris Ogden, Cytomics' 00:00:15.908 -- 00:00:19.991 Chief Financial Officer. Please go ahead. 00:00:20.473 -- 00:00:23.897 Thank you. Good afternoon, and thank you for joining us. 00:00:23.897 -- 00:00:28.142 Before we begin, I'd like to remind everyone that during this call, we'll be making forward-looking 00:00:28.142 -- 00:00:33.206 statements. Because forward-looking statements relate to the future, they are subject 00:00:33.206 -- 00:00:37.733 to inherent uncertainties and risks that are difficult to predict, and many of which 00:00:37.733 -- 00:00:40.057 are outside of our control. 00:00:40.057 -- 00:00:45.025 Important risks and uncertainties are set forth in our most recent public filings with 00:00:45.025 -- 00:00:48.050 the SEC at SEC.gov. 00:00:48.050 -- 00:00:52.738 We undertake no obligation to update any forward-looking statements, whether as a result 00:00:52.738 -- 00:00:56.967 of new information, future developments, or otherwise. 00:00:56.967 -- 00:01:01.092 Earlier this afternoon, we issued a press release that includes a summary of our third 00:01:01.092 -- 00:01:07.381 quarter 2025 financial results and highlights recent progress at Cytomix. 00:01:07.381 -- 00:01:12.027 We encourage everyone to read today's press release and the associated materials, which 00:01:12.027 -- 00:01:14.650 have been filed with the SEC. 00:01:14.650 -- 00:01:19.997 Additionally, the press release recor...